Angiodynamics (ANGO) Share-based Compensation (2010 - 2026)

Angiodynamics has reported Share-based Compensation for 17 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 11.93% year-over-year to $2.7 million; the trailing twelve-month figure through Feb 2026 stood at $11.7 million (up 16.55% YoY), and the FY2025 full-year result was $9.8 million, down 7.19% from the prior year.
• Share-based Compensation for Q1 2026 stood at $2.7 million, down from $2.9 million in the prior quarter.
• The five-year high for Share-based Compensation was $4.5 million in Q3 2025, with the low at $1.6 million in Q2 2025.
• Historically, Share-based Compensation has averaged $2.8 million across 5 years, with a median of $2.7 million in 2026.
• Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 43.97% — and 2024, when it jumped 44.87%.
• Angiodynamics' Share-based Compensation stood at $3.4 million in 2022, then sank by 43.97% to $1.9 million in 2023, then surged by 34.68% to $2.5 million in 2024, then gained by 14.36% to $2.9 million in 2025, then fell by 7.16% to $2.7 million in 2026.
• The last three Share-based Compensation figures came in at $2.7 million (Q1 2026), $2.9 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.